Viewing Study NCT02996396



Ignite Creation Date: 2024-05-06 @ 9:30 AM
Last Modification Date: 2024-10-26 @ 12:15 PM
Study NCT ID: NCT02996396
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2022-06-07
First Post: 2016-12-12

Brief Title: Nellix Registry Study EVAS-Global
Sponsor: Endologix
Organization: Endologix

Study Overview

Official Title: Multicenter Observational Registry to Assess Outcomes of Patients Treated With the CE Marked Nellix System for Endovascular Abdominal Aortic Aneurysm Repair
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2022-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: EVAS FORWARD 2
Brief Summary: Multicenter single arm open label registry study with consecutive eligible patient enrollment at each site All subjects undergoing the Endovascular Aneurysm Sealing System EVAS with the Nellix-System Subjects will be followed procedurally to discharge and as per institutional standard of care thereafter through to 5 years total follow-up commitment
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None